Gilead’s Virus Drug Remdesivir Gains Approval From FDA

Oct.22 — The U.S. Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the coronavirus. Still, the drug hasn’t been proven to…